drugset / Trial / NCT00643669

24 Hour IOP Lowering Efficacy of AL-3789

NCT00643669

Phase 2 Completed 25 enrolled Alcon Research
RandomizedSingle-groupSingle-blindTreatment

Summary

The objective of this study was to describe the intraocular pressure-lowering efficacy of AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated control. Patients received one treatment of AL-3789. Twenty-eight days after treatment, IOP was measured every 4 hours, beginning at 8 AM for 24 hours.

Timeline

Start
2008-02
Primary completion
2008-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Anecortave Acetate Small molecule 0.8 ml Other

Indications